The study concluded that the role of both BMP and TGFB1 signaling in the pathogenesis of IPF and post-COVID-19 fibrosis (PCF) may have implications for the development of future treatments. The gene discussed is TGFB1; the disease is idiopathic pulmonary fibrosis.